A double-blind, randomized clinical trial to evaluate the efficacy of Duloxetine against pain associated with Parkinson's disease with depression.
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Duloxetine (Primary)
- Indications Depression; Pain
- Focus Therapeutic Use
- 27 Sep 2017 Planned number of patients changed from 40 to 50.
- 08 Aug 2017 Planned number of patients changed from 100 to 40.
- 07 Apr 2015 New trial record